1. Zhang, Yuanping, Qiu, Jiliang, Zuo, Dinglan, Li, Binkui, Yuan, Yunfei. 2021. SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial-mesenchymal transition. In FEBS open bio, 11, 1757-1770. doi:10.1002/2211-5463.13175. https://pubmed.ncbi.nlm.nih.gov/33934562/
2. Cai, Jihao, Zhou, Minglei, Xu, Jianxin. 2021. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma. In World journal of surgical oncology, 19, 241. doi:10.1186/s12957-021-02354-8. https://pubmed.ncbi.nlm.nih.gov/34389000/
3. Hua, Tian, Wang, Rui-Min, Zhang, Xiao-Chong, Liu, Deng-Xiang, Wang, Wei. . ZNF76 predicts prognosis and response to platinum chemotherapy in human ovarian cancer. In Bioscience reports, 41, . doi:10.1042/BSR20212026. https://pubmed.ncbi.nlm.nih.gov/34793589/
4. Zhang, Zaifeng, Zhang, Lili, Li, Jiangtao, Xiao, Fei, Zhang, Chunli. 2024. Comprehensive analysis of m6A methylome alterations after azacytidine plus venetoclax treatment for acute myeloid leukemia by nanopore sequencing. In Computational and structural biotechnology journal, 23, 1144-1153. doi:10.1016/j.csbj.2024.02.029. https://pubmed.ncbi.nlm.nih.gov/38510975/
5. Riveros-McKay, Fernando, Mistry, Vanisha, Bounds, Rebecca, Barroso, Inês, Farooqi, I Sadaf. 2019. Genetic architecture of human thinness compared to severe obesity. In PLoS genetics, 15, e1007603. doi:10.1371/journal.pgen.1007603. https://pubmed.ncbi.nlm.nih.gov/30677029/